Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05611307 · ClinicalTrials.gov registry record
Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 31
- Enrollment target
NCT05611307: Clinical Trial study, sponsored by Indiana University.
NCT05611307 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05611307 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 31 participants
- Enrollment target
Study Summary
Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant
Primary Outcome
HDL, LDL, Tg, Cholesterol, Novel Lipid biomarkers using blood draws
Interventions
- DIAGNOSTIC_TEST Lipid profile
- DIAGNOSTIC_TEST Coronary artery assessment
- DIAGNOSTIC_TEST Hormone levels for hypogonadism
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-10-11 |
| Est. Completion | 2024-12-04 |
Why NCT05611307 stopped before completion
NCT05611307 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Lipid profile is the first listed.
NCT05611307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05611307 about?
NCT05611307 is a clinical study titled "Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors". Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant
What is the current status of trial NCT05611307?
This trial is currently terminated. The enrollment target is 31 participants. The study started on 2022-10-11. Estimated completion is 2024-12-04.
What interventions are being tested in trial NCT05611307?
The interventions under investigation include: Lipid profile (DIAGNOSTIC_TEST), Coronary artery assessment (DIAGNOSTIC_TEST), Hormone levels for hypogonadism (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05611307?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI